Wealthfront’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Wealthfront's AGN Position: Q3 2018 in Review
Wealthfront increased its Allergan plc (AGN) stake by 48% in Q3 2018, buying an estimated $503K and bringing the position to 8,493 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #160.
Wealthfront first reported a position in AGN in Q1 2014 and has held it in 19 quarters since. The position peaked at $2.61M in Q2 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.
- Wealthfront held 8,493 shares of Allergan plc worth $1.62M as of Q3 2018.
- Wealthfront bought 2,736 Allergan plc shares in Q3 2018, an estimated $503K.
- Allergan plc made up 0.02% of Wealthfront's portfolio in Q3 2018, its #160 holding.
- Wealthfront first reported a position in Allergan plc in Q1 2014 and has held it in 19 quarters since.
- Wealthfront's Allergan plc position peaked at $2.61M in Q2 2017.
- 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.
Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.